NCT06510673

Brief Summary

PURPOSE: To compare the effect of Extracorporeal shock wave therapy and high-power LASER therapy for the treatment of patients with calcaneal spur Background: Calcaneal spur is a common musculoskeletal disorder of the foot that affect the quality-of-life Conservative treatment modalities include, cold application, platelet-rich plasma therapy (PRP), shoe modification, therapeutic ultrasound, extracorporeal shock wave therapy (ESWT), laser therapy (LLLT) are commonly used in the treatment of calcaneal spur. HYPOTHESES: There will be difference between Extracorporeal shock wave therapy and High- power LASER therapy on pain intensity in patients with calcaneal spur There will be difference between Extracorporeal shock wave therapy and High- power LASER therapy on function in patients with calcaneal spur. There will be difference between Extracorporeal shock wave therapy and High- power LASER therapy on the size of calcaneal spur in patients with calcaneal spur. RESEARCH QUESTION: Is there any difference between the effect of Extracorporeal shock wave therapy and High-power LASER on calcaneal spur?

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
72

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Oct 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 15, 2024

Completed
4 days until next milestone

First Posted

Study publicly available on registry

July 19, 2024

Completed
2 months until next milestone

Study Start

First participant enrolled

October 1, 2024

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2025

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2025

Completed
Last Updated

August 9, 2024

Status Verified

August 1, 2024

Enrollment Period

6 months

First QC Date

July 15, 2024

Last Update Submit

August 7, 2024

Conditions

Outcome Measures

Primary Outcomes (3)

  • Pain Visual Analog Scale

    It is a self reported outcome which is a 10 cm line with zero at one end indicating no pain and 10 at the other end indicating maximum pain. Patient will be asked to mark the current pain on the scale and the distance from the starting point (0) will be measured

    Baseline and after one month

  • foot function index.

    measure the impact of foot pathology on function in terms of pain, disability and activity restriction. it is a self-administered index

    Baseline and after one month

  • calcaneal Spur length

    Spur length will be measured by MRI

    Baseline and after one month

Study Arms (4)

Shockwave therapy

EXPERIMENTAL

Shockwave therapy for calcaneal spur

Other: Shockwave therapy

High-power LASER therapy

EXPERIMENTAL

High-power LASER therapy for calcaneal spur

Other: High power LASER

Control

SHAM COMPARATOR

cold application with receive 6 sessions of sham LASER therapy.

Other: Ice applicationOther: Sham LASER

Platelet rich plasma

EXPERIMENTAL

Platelet-rich plasma injection for the heel

Drug: Platelet rich plasma

Interventions

Platelet-rich plasma for the heel

Platelet rich plasma

High power LASER sessions for the heel

High-power LASER therapy

Shockwave therapy sessions for the heel

Shockwave therapy

Ice application for the heel

Control

Sham LASER for the heel

Control

Eligibility Criteria

Age25 Years - 40 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • diagnosed with calcaneal spur based on clinical examination and radiological findings.

You may not qualify if:

  • were as follows: acute trauma to the foot, history of fracture or surgery, lower extremity neurological deficit, polyneuropathy, radicular pain, autoimmune diseases tumor, thrombosis, soft tissue or bone infection, or skin disorder.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Badr University in Cairo (BUC)

Cairo, 12311, Egypt

Location

MeSH Terms

Conditions

Heel Spur

Interventions

Extracorporeal Shockwave Therapy

Condition Hierarchy (Ancestors)

ExostosesHyperostosisBone DiseasesMusculoskeletal DiseasesFoot Diseases

Intervention Hierarchy (Ancestors)

Ultrasonic TherapyDiathermyHyperthermia, InducedTherapeuticsPhysical Therapy ModalitiesRehabilitation

Study Officials

  • Doaa Elsayed

    Department of Physical therapy for Woman's Health, Faculty of Physical Therapy, Badr University in Cairo, Cairo, Egypt

    STUDY CHAIR
  • Doha Hamed

    Basic Sciences Department, Faculty of Physical Therapy, Badr University in Cairo

    STUDY CHAIR
  • Ahmed Zakaria

    Department of orthopedic surgery, Helwan University

    STUDY CHAIR
  • Omnya Samy

    Department of Physical Therapy for Pediatrics and Pediatric Surgery, Faculty of Physical Therapy, Badr University in Cairo

    STUDY DIRECTOR
  • Fatma Zidan

    Department of Physical therapy for Neuromuscular Disorders & its Surgery, Faculty of Physical Therapy, Badr University in Cairo

    STUDY DIRECTOR
  • Doaa Saeed

    Department of Physical Therapy for Women's Health, Faculty of Physical Therapy, Badr University in Cairo, Cairo, Egypt

    STUDY CHAIR

Central Study Contacts

Doha Hamed, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecturer

Study Record Dates

First Submitted

July 15, 2024

First Posted

July 19, 2024

Study Start

October 1, 2024

Primary Completion

April 1, 2025

Study Completion

June 1, 2025

Last Updated

August 9, 2024

Record last verified: 2024-08

Data Sharing

IPD Sharing
Will not share

Locations